Diastolic heart failure

Heart and Lung: Journal of Acute and Critical Care

Volumn 37, Issue 6, 2008, Pages 405-416

  Gary, Rebecca ^a   Davis, Leslie ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CARDIAC AGENT; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LOSARTAN; PLACEBO; UNCLASSIFIED DRUG;

AGING; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DIASTOLIC HEART FAILURE; DRUG COST; DRUG EFFECT; EXERCISE; GERIATRIC CARE; HOSPITALIZATION; HUMAN; HYPERTENSION; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR; SEX DIFFERENCE; SURVIVAL; UNSPECIFIED SIDE EFFECT;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEART FAILURE, DIASTOLIC; HEART FUNCTION TESTS; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; UNITED STATES;

EID: 55049111235     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2007.12.002     Document Type: Article

References (96)

1. Miller L.W., and Missov E.D. Epidemiology of heart failure. Cardiol Clin 19 (2001) 547-555
2. Kitzman D.W. Diastolic heart failure in the elderly. Heart Fail Rev 7 (2002) 17-27
3. Ahmed A. Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure. J Am Geriatr Soc 60A (2005) 1339-1344
4. Thomas M.D., Fox K.F., Coats A.J., and Sutton G.C. The epidemiology enigma of heart failure with preserved systolic function. Eur J Heart Fail 6 (2004) 125-136
5. Aronow W.S. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure. Cardiol Rev 14 (2006) 108-124
6. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
7. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., and Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 33 (1999) 1948-1955
8. Rich M.W. Heart failure in older adults. Med Clin North Am 90 (2006) 863-885
9. Kitzman D.W., Gardin J.M., Gottdiener J.S., et al. Importance of heart failure with preserved systolic function in patients > 65 years of age. Am J Cardiol 87 (2001) 413-419
10. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 35 (2000) 1628-1637
11. O'Connor C.M., Gattis W.A., Shaw L., et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 86 (2000) 863-867
12. He J., Ogden L.G., Bazano L.A., Vupputuri S., Loria C., and Whelton P.K. Risk factors for congestive heart failure in US men and women. Arch Intern Med 161 (2001) 996-1002
13. Smith G.L., Masoudi F.A., Vaccarino V., Radford M.J., and Krumholz H.M. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41 (2003) 1510-1518
14. Little W.C., and Brucks S. Therapy for diastolic heart failure. Prog Cardiovasc Dis 47 (2005) 380-388
15. LeJemtel T., and Sonnenblick E.H. Heart failure: adaptive and maladaptive processes. Circulation 87 suppl VII (1993) VII-1-3
16. Zile M.R., Baicu C.F., and Bonnema D.D. Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis 47 (2005) 307-313
17. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part I. Circulation 105 (2002) 1387-1398
18. Gottdiener J.S., Kitzman D.W., Aurigemma G.P., Arnold A.M., and Manolio T.A. Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or = 65 years of age (the cardiovascular health study). Am J Cardiol 97 (2006) 83-89
19. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure Part II: causal mechanisms and treatment. Circulation 105 (2002) 1503-1508
20. Gaasch W.H., and Zile M.R. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 55 (2004) 373-394
21. Kitzman D.W. Heart failure in the elderly: systolic and diastolic dysfunction. Am J Geriatr Cardiol 5 (1996) 2026
22. Vasan R.S., and Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101 (2000) 2118-2121
23. Wei T., Zeng C., Chen L., et al. Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide. Int J Clin Pract 59 (2005) 891-894
24. Iwanaga Y., Nishi I., Furuichi S., et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 47 (2006) 742-748
25. McKee P.A., Castelli W.P., McNamara P.M., and Kannel W.B. The natural history of congestive heart failure: the Framingham study. N Engl J Med 285 (1971) 1441-1446
26. Ho K.K., Pinsky J.L., Kannel W.B., and Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22 4 Suppl A (1993) 6A-13A
27. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community: a study of all incident cases in Olmstead County, Minnesota, in 1991. Circulation 98 (1998) 2282-2289
28. Devereux R.B., Roman M.J., Liu J.E., et al. Congestive heart failure despite normal left ventricular systolic function in a population based sample: The Strong Heart Study. Am J Cardiol 86 (2000) 1090-1096
29. McCullough P.A., Philbin E.F., Spertus J.A., Katz S., Sandberg K.R., and Weaver W.D. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) Study. J Am Coll Cardiol 39 (2002) 60-69
30. McMurray J., Ostergren J., Pfeffer M., et al., CHARM committees and investigators. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur J Heart Fail 5 (2003) 261-270
31. Yusuf S., Pfeffer M.A., Swedberg K., et al., CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781
32. Granger C.B., McMurray J.J., Yusuf S., et al., CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 362 (2003) 772-776
33. McMurray J.J., Ostergren J., Swedberg K., et al., CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 362 (2003) 767-771
34. Carson P., Massie B.M., McKelvie R., et al., I-PRESERVE Investigators. The Irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail 11 (2005) 576-585
35. Ahmed A., Aronow W.S., and Fleg J.L. Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J 151 (2006) 444-450
36. Tarantini L., Faggiano P., Senni M., et al. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure. Ital Heart J 3 (2002) 656-664
37. Taffet G.E., Teasdale T.A., Bleyer A.J., Kutka N.J., and Luchi R.J. Survival of elderly men with congestive heart failure. Age Ageing 21 (1992) 49-55
38. Ahmed A., Roseman J.M., Duxburt A.S., Allman R.M., and DeLong J.F. Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure. Am Heart J 144 (2002) 365-372
39. Aronow W.S., Ahn C., and Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol 66 (1990) 1257-1259
40. East M.A., Peterson E.D., Shaw L.K., Gattis W.A., and O'Connor C.M. Racial differences in the outcomes of patients with diastolic heart failure. Am Heart J 148 (2004) 151-156
41. Mensah G.A., Mokdad A.H., Ford E.S., Greenlund K.J., and Croft J.B. State of disparities in cardiovascular health in the United States. Circulation 111 (2004) 1233-1241
42. Lakatta E.G. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev 7 (2002) 29-49
43. Devereux R.B., Pickering T.G., and Harshfield G.A. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 68 (1983) 470-476
44. Gradman A.H., Pangan P., and Germain M. Lack of correlation between clinic and 24 hour ambulatory blood pressure in subjects participating in a therapeutic drug trial. J Clin Epidemiol 42 (1989) 1049-1054
45. Gradman A.H., and Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 48 (2006) 326-341
46. Lamb H.J., Beyerbacht H.P., van der Laarse A., et al. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 99 (1999) 2261-2267
47. Bonow R.O., and Udelson J.E. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med 117 (1992) 502-510
48. Leite-Moreira A.F., Correia-Pinto J., and Gillebert T.C. Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction. Cardiovasc Res 43 (1999) 344-353
49. Sadoshima J., Xu Y., Slayter H.S., and Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75 (1993) 977-984
50. Van Heugten H.A., De Jonge H.W., Bezstarosti K., Sharma H.S., Verdouw P.D., and Lamers J.M. Intracellular signaling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes. Ann N Y Acad Sci 752 (1995) 343-352
51. Iribarren C., Karter A.J., Go A.S., et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 103 (2001) 2668-2673
52. Hardin N. The myocardial and vascular pathology of diabetic cardiomyopathy. Coron Artery Dis 7 (1996) 99-108
53. Peterson L.R., Waggoner A.D., Schechtman K.B., et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 43 (2004) 1399-1404
54. Kannel W.B., Hjortland M., and Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34 (1974) 29-34
55. Zabalgoitia M., Ismaeil M.F., Anderson L., and Maklady F.A. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 87 (2001) 320-323
56. Liu J.E., Robbins D.C., Palmieri V.S., et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol 41 (2003) 2022-2028
57. Braunstein J.B., Anderson G.F., Gerstenblith G., et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42 (2003) 1226-1233
58. Lien C.T.C., Gillespie N.D., Struthers A.D., and McMurdo M.E.T. Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail 4 (2002) 91-98
59. Paul S. Diastolic dysfunction. Crit Care Nurs Clin N Am 15 (2003) 495-500
60. Beattie S. Heart failure with preserved LV function: pathophysiology, clinical presentation, treatment, and nursing implications. J Cardiovasc Nurs 14 (2000) 24-37
61. Kitzman D.W. Exercise intolerance. Prog Cardiovas Dis 47 (2005) 367-379
62. Little W.C., Kitzman D.W., and Cheng C.P. Diastolic dysfunction as a cause of exercise intolerance. Heart Fail Rev 5 (2000) 301-306
63. Brubaker P.H., Marburger C.T., Morgan T.M., Fray B., and Kitzman D.W. Exercise responses of elderly patients with diastolic versus systolic heart failure. Med Sci Sports Exerc 35 (2003) 1477-1485
64. Quinones M.A. Assessment of diastolic dysfunction. Prog Cardiovasc Dis 47 (2005) 340-355
65. Smiseth O.A., and Thompson C.R. Atrioventricular filling dynamics, diastolic dysfunction and dysfunction. Heart Fail Rev 5 (2000) 291-299
66. Wu E.B., and Yu C.M. Management of diastolic heart failure-a practical review of pathophysiology and treatment trial data. Int J Clin Pract 59 (2005) 1239-1246
67. Galderesi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound 3 (2005) 9
68. Erhardt L.R. A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure. Int J Clin Pract 59 (2005) 571-578
69. Heart Failure Society Of America. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 (2006) 10-38
70. Kitzman D.W. Diastolic dysfunction and function: diastolic dysfunction in the elderly: Genesis and diagnostic and therapeutic implications. Cardiol Clin 18 (2000) 1-28
71. Hogg K., and McMurray J. Neurohormonal pathways in heart failure with preserved systolic function. Prog Cardiovasc Dis 47 (2005) 357-366
72. Mielniczuk L., and Stevenson L.W. Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers in the management of congestive heart failure patients: what have we learned from recent clinical trials?. Curr Opin Cardiol 20 (2005) 250-255
73. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 38 (2001) 2101-2113
74. Warner J.G., Metzger C., Kitzman D.W., Wesley D.J., and Little W.C. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 33 (1999) 1567-1572
75. Little W.C., Zile M.R., Klein A., Appleton C.P., Kitzman D.W., and Wesley-Farrington D.J. Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction. Am J Cardiol 98 (2006) 383-385
76. Pitt B., and Rajagopalan S. Aldosterone receptor antagonists for heart failure: current status, future indications. Cleve Clin J Med 73 (2006) 257-268
77. Ahmed A., Rich M.W., Love T.E., et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27 (2006) 178-186
78. Jones R.C., Francis G.S., and Lauer M.S. Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 44 (2004) 1025-1029
79. Pina I.L., Apstein C.S., Balady G.J., et al., American Heart Association Committee on exercise, rehabilitation and prevention. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation and prevention. Circulation 107 (2003) 1210-1225
80. Ades P.A. Cardiac rehabilitation in older coronary patients. J Am Geriatr Soc 47 (1999) 98-105
81. Gary R.A., Sueta C.A., Dougherty M., et al. Home-based exercise improves functional performance and quality of life in women with diastolic heart failure. Heart Lung 33 (2004) 210-218
82. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14 (1982) 377-381
83. Gary R. Exercise self-efficacy in older women with diastolic heart failure: results of a walking program and education intervention. J Gerontol Nurs 32 (2006) 31-39
84. Schneider N.M. Managing congestive heart failure using home telehealth. Home Healthc Nurse 22 (2004) 19-22
85. Smart N., Haluska B., Jeffriess L., and Marwick T.H. Predictors of a sustained response to exercise training in patients with chronic heart failure: a telemonitoring study. Am Heart J 150 (2005) 1240-1247
86. Dunbar S.B., Clark P.C., Deaton C., Smith A.L., De A.K., and O'Brien M.C. Family education and support interventions in heart failure: a pilot study. Nurs Res 54 (2005) 158-166
87. Artinian N.T., Magnan M., Christian W., and Lange M.P. What do patients know about their heart failure?. Appl Nurs Res 15 (2002) 200-208
88. Carlson B., Riegel B., and Moser D. Self-care abilities of patients with heart failure. Heart Lung 30 (2001) 351-359
89. Turvey C.L., Klein D.M., and Pies C.J. Depression, physical impairment, and treatment of depression in chronic heart failure. J Cardiovasc Nurs 21 (2006) 178-185
90. Koenig H.G. Depression outcome in inpatients with congestive heart failure. Arch Intern Med 166 (2006) 991-996
91. Joynt K.E., Whellan D.J., and O'Connor C.M. Why is depression bad for the failing heart?. A review of the mechanistic relationship between depression and heart failure. J Card Fail 10 (2004) 258-271
92. Konstam V., Moser D.K., and De Jong M.J. Depression and anxiety in heart failure. J Card Fail 11 (2005) 455-463
93. Krumholz H.M., Butler J., Miller J., et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 97 (1998) 958-964
94. Derogatis L.R., and Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 13 (1983) 595-605
95. Herbert K.A., Horswell R.L., Dy S., et al. Mortality benefit of a comprehensive heart failure disease management program in indigent patients. Am Heart J 151 (2006) 478-483
96. Stewart S., and Horowitz J.D. Home-based intervention in congestive heart failure: long term implications on readmission and survival. Circulation 105 (2002) 2861-2866